You clicked so you are probably thinking oh boy, yet another penny stock. HYPR is a company that makes low field portable MRI scanners specifically for neurological care and support. Surmised from my long position, it appears a machine goes for shy of 1 million with LTS options provided via the company. Expansion phase appears promising as forward looking statements around expansion in Europe and India (where low field, low cost mri can fill a roll that large strength machines can without helium costs and shielding) have met my expectations.
Options chain is near useless, but swings on stock insane due to volume. Leadership acquires more share than sold, but there was an additional class offering at like 1.20\~ a share to obtain a financial runway going to 2028.
My limited position of 5000 shares acquired over the last 3 years have an average of 1.31 a share. With revenue improving each quarter, I see a potential price target within 3-4 years at $3.50. I also see the potential of acquisition as the tech is pretty sick.
TLDR: HYPR has the fundamentals of a starting biotech company. I like their product and their forward looking statement. I believe that the story may be just beginning with them. Feel free to disagree below, but do add targeted points; I want to factor other opinions